Position in MDCX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$189
-$6 QoQ
Shares Held
425
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 23 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MDCX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HAZLETT, BURT & WATSON, INC. holds $14,735,791 across 13 Drug Manufacturers - General names. MDCX ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,428 | $4,680,142 | |
| 2 | LLY |
ELI LILLY & Co
|
2,569 | $3,081,275 | |
| 3 | ABBV |
AbbVie Inc.
|
11,476 | $2,887,808 | |
| 4 | AMGN |
Amgen Inc
|
3,647 | $1,320,642 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,130 | $787,698 | |
| 6 | NVS |
Novartis AG
|
2,835 | $444,300 | |
| 7 | NVO |
Novo Nordisk A S
|
7,889 | $378,192 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,958 | $373,710 |
All Filings in MDCX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $189 | 425 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $195 | 425 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1 | 425 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||